Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,121 | 264 | 90.7% |
| Education | $418.96 | 5 | 7.4% |
| Unspecified | $106.67 | 1 | 1.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $763.58 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $749.51 | 35 | $0 (2024) |
| Amgen Inc. | $604.15 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $547.68 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $466.12 | 41 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $428.79 | 16 | $0 (2024) |
| Lilly USA, LLC | $386.85 | 23 | $0 (2024) |
| Dermavant Sciences, Inc. | $320.47 | 17 | $0 (2024) |
| Incyte Corporation | $297.98 | 14 | $0 (2024) |
| UCB, Inc. | $264.07 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 59 | Amgen Inc. ($191.23) |
| 2023 | $2,124 | 98 | Janssen Biotech, Inc. ($415.75) |
| 2022 | $1,114 | 54 | E.R. Squibb & Sons, L.L.C. ($142.60) |
| 2021 | $980.04 | 56 | Janssen Biotech, Inc. ($215.27) |
| 2020 | $16.29 | 1 | Allergan, Inc. ($16.29) |
| 2018 | $106.67 | 1 | AbbVie, Inc. ($106.67) |
| 2017 | $18.89 | 1 | Valeant Pharmaceuticals North America LLC ($18.89) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.69 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $66.33 | General |
| Category: RETT SYNDROME | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $26.80 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Oncology | ||||||
| 08/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Immunology | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.32 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | Smith+Nephew, Inc. | GRAFIX (Medical Supply) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Other Advanced Wound Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,079 | 2,905 | $420,723 | $147,077 |
| 2022 | 18 | 2,122 | 2,906 | $425,297 | $150,130 |
| 2021 | 19 | 2,091 | 2,993 | $441,823 | $172,353 |
| 2020 | 19 | 1,969 | 9,016 | $629,943 | $223,953 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 619 | 808 | $121,200 | $42,602 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 278 | 318 | $58,830 | $21,514 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 293 | $58,600 | $20,355 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 245 | 290 | $43,500 | $9,219 | 21.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 30 | 30 | $19,050 | $8,389 | 44.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 19 | 27 | $12,075 | $8,277 | 68.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 125 | 146 | $28,178 | $8,188 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 107 | 107 | $17,120 | $5,955 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 133 | 156 | $15,600 | $5,375 | 34.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $9,605 | $4,259 | 44.3% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 14 | 15 | $5,250 | $2,985 | 56.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 152 | 570 | $6,264 | $2,429 | 38.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 27 | $5,940 | $2,063 | 34.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $7,600 | $1,972 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,680 | $1,118 | 30.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 27 | $2,808 | $885.10 | 31.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $3,250 | $815.45 | 25.1% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $2,173 | $678.00 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 639 | 856 | $128,050 | $44,432 | 34.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 251 | 298 | $55,130 | $21,047 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 258 | $51,600 | $19,358 | 37.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 160 | 175 | $33,775 | $9,696 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 232 | 275 | $41,250 | $9,025 | 21.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 27 | 29 | $16,385 | $7,804 | 47.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 26 | 27 | $17,145 | $7,536 | 44.0% |
About Troy Davis, PA-C
Troy Davis, PA-C is a Dermatology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790793685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Troy Davis, PA-C has received a total of $5,646 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 270 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,121).
As a Medicare-enrolled provider, Davis has provided services to 8,261 Medicare beneficiaries, totaling 17,820 services with total Medicare billing of $693,514. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Missoula, MT
- Active Since 08/04/2006
- Last Updated 01/24/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1790793685
Products in Payments
- TREMFYA (Drug) $666.33
- Otezla (Drug) $604.15
- Sotyktu (Drug) $547.68
- TALTZ (Drug) $361.89
- SKYRIZI (Biological) $351.26
- VTAMA (Drug) $320.47
- OPZELURA (Drug) $297.98
- Cimzia (Drug) $238.31
- COSENTYX (Biological) $225.04
- COSENTYX (Drug) $200.51
- ILUMYA (Biological) $132.52
- RINVOQ (Biological) $129.96
- Humira (Biological) $106.67
- DUPIXENT (Biological) $84.76
- REMICADE (Biological) $83.18
- Restrata Wound Matrix (Device) $79.16
- Odomzo (Drug) $78.20
- DUOBRII (Drug) $74.27
- BOTOX (Biological) $70.29
- DAYBUE (Drug) $66.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Missoula
Shannon Foster, M.d, M.D
Dermatology — Payments: $11,217
Jessica Sempler, M.d, M.D
Dermatology — Payments: $5,358
Andrew Tegeder, Md, MD
Dermatology — Payments: $3,539
Erika Hagstrom, Md, MD
Dermatology — Payments: $1,643
Jacob Inda, Md, MD
Dermatology — Payments: $1,488
Allyson Yelich, D.o, D.O
Dermatology — Payments: $843.25